Sustainability| More...
 

Biosimilars

The White House Deal with Big Pharma

James Love | Posted 09.06.2009 | Politics

Read More: Biosimilars, Jeffrey Kindler, Phrma, Billy Tauzin, Pfzier, Big Pharma, Pharmaceutical Companies, Pharmaceutical Industry, Max Baucus, Henry Waxman, Politics News
James Love

The White House has abandoned any real effort to control costs in the pharma sector and Democrats have taken this hands-off approach as a green light to side with Big Pharma.

Read Post

Eshoo and Barton Team Up to Block Generic Biologic Medicines

James Love | Posted 08.31.2009 | Politics

Read More: Biosimilars, Anna Eshoo, Phrma, Eshoo Barton Amendment, PhRMA Lobby, Joe Barton, Henry Waxman, Health Care, Bio, Politics News
James Love

The Eshoo/Barton amendment, which has the support of many newly pro-PhRMA democrats, will extend the period of monopolies for biologic medicines.

Read Post

Howard Dean Claims He Is "Actually Not a Shill For the BIO." Then Stop Acting Like One

James Love | Posted 08.22.2009 | Politics

Read More: Biosimilars, Howard Dean, Dean BIO, Biotechnology Industry Association, Dean and Biotech, Biotech, Bio, Dean Lobbyist, Politics News
James Love

I have always liked Howard Dean, but nothing excuses what he is doing now.

Read Post

Howard Dean -- Now a Shill for BIO

James Love | Posted 08.20.2009 | Politics

Read More: Biosimilars, Howard Dean, Joe Trippi, Bio, Jim Greenwood, Politics News
James Love

What exactly would it take to make Howard Dean a lobbyist? A special badge from the Wizard of Oz?

Read Post

Joe Trippi Admits He Works for BIO, While He Plugs BIO Bill in HuffPo

James Love | Posted 08.17.2009 | Politics

Read More: Biosimilars, Howard Dean, Joe Trippi, Bio, Politics News
James Love

Trippi posted the lame assertion that "I have never been paid by anyone to post or blog anything by anyone." Well, what is BIO paying Joe to do?

Read Post

Key Democrats Back BIO Industry Against Consumers to Delay Generic Medicines (Biosimilars)

James Love | Posted 08.16.2009 | Politics

Read More: Senator Kennedy, Biosimilars, Anna Eshoo, John Conyers, Generic Medication, Politics News
James Love

Unlike for pharmaceutical drugs, there is no easy way to get FDA approval for a generic biologic product. Congress is considering an FDA reform to fix this, but it is being derailed by the BIO.

Read Post